Edition:
United Kingdom

Esperion Therapeutics Inc (ESPR.OQ)

ESPR.OQ on NASDAQ Stock Exchange Global Market

47.26USD
18 Sep 2018
Change (% chg)

$0.07 (+0.15%)
Prev Close
$47.19
Open
$47.00
Day's High
$47.60
Day's Low
$46.01
Volume
128,786
Avg. Vol
256,040
52-wk High
$82.68
52-wk Low
$33.06

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Timothy Mayleben

57 2012 President, Chief Executive Officer, Director

Richard Bartram

36 2018 Chief Financial Officer and Principal Financial Officer

Narendra Lalwani

65 2014 Chief Operating Officer, Executive Vice President - Research & Development

Nicole Vitullo

60 2015 Independent Lead Director

Roger Newton

67 2016 Director